Introduction: The Nitric Oxide Synthase Reaction
Two main lines of research lead to the discovery of nitric oxide (NO) synthase: One started with the investigation of a labile factor derived from endothelium which causes smooth muscle cells to relax. This factor called endothelium derived relaxing factor, was then characterized to be equivalent to NO and to be biosynthetically derived from L-arginine. An enzyme carrying out this reaction was purified from rat cerebellum, cloned and expressed (for detailed references see e. g. 1).
Another main line started from the investigation of the source of endogenous nitrate formation in mammals. The endogenously formed nitrate was shown to be derived from the N-guanidino nitrogen of L-arginine. Nitrate biosynthesis was shown to be enhanced by lipopolysaccaride in rats. A cellular source was found to be the murine macrophage, which can be triggered by cytokines to express an enzyme activity forming NO from L-arginine.
Pteridine Dependence of Nitric Oxide Synthase
It was in these macrophage cytosols that two groups reported that the enzyme activity requires a low molecular weight cofactor for full activity, which was characterized to be tetrahydrobiopterin (2, 3) . In addition, manipulation of intracellular tetrahydrobiopterin levels in intact cells was found to modulate the amount of nitrogen oxides formed from L-arginine in cytokine-treated murine fibroblasts (see contribution by Gabriele Werner-Felmayer et al., this issue). In contrast to the NO synthase from macrophages, the enzyme from brain was thought to be independent of tetrahydrobiopterin due to the fact that enzyme activity was detected without exogenous addition of pteridines. On the other hand, the enzyme purified from porcine cerebellum was shown to be activated by tetrahydrobiopterin to an extent similar to the macrophage cytosolic reaction. Further, the pure cerebellum enzyme contains tightly bound tetrahydrobiopterin. thus explaining the basal activity to be consistent with a pteridine dependence of the NO synthase reaction (4) in the brain. These findings were also confirmed for the human cerebellum enzyme. Tetrahydrobiopterin but not neopterin derivatives are copurified with the activity and 6R-tetrahydrobiopterin stimulates the human NO synthase in a manner similar to the porcine enzyme (Klatt, P., Werner, E. R., Heinzel, B., Mayer, B., Arnbach, E. & Wächter, H., unpublished).
The molecular nature for the stimulatory action is not yet clear. While the amount of NO formed stoichiometrically depends on NADPH (1.5 mol are required per mol NO), one molecule tetrahydrobiopterin can catalyze at least ten molecules of NO to be formed (4). Giovanelli et al. additionally presented evidence that the exogenously added tetrahydrobio-pterin does not recycle in the reaction. Using measurement of quinonoid dihydrobiopterin with HPLC and electrochemical detection instead of the enzymatic assay we are able to confirm these findings. Nevertheless, the possibility remains that the tightly bound tetrahydrobiopterin may undergo a recycling in the catalysis of NO formation. Compared to the known pteridine dependent aromatic amino acid hydroxylation reactions, the NO synthase reaction appears to be more complex. Three reducing equivalents derived from NADPH are involved. In addition to tetrahydrobiopterin the enzyme contains FAD and FMN as coenzymes. In absence of arginine and tetrahydrobiopterin, the enzyme reduces oxygen to hydrogenperoxide in an uncoupled reaction (4) . The amount of pteridine required for stimulating the activity is in the submicromolar range. The stimulatory action is remarkably selective for 6R-tetrahydrobiopterin. In addition, the published sequence lacks the putative pteridine binding sequence of aromatic amino acid hydroxylases proposed by R. G. H. Cotton and colleagues.
Physiological Relevance of Tetrahydrobiopterin for Nitric Oxide Synthesis in vivo
The findings with intact cells (see G. Werner-Felmayer et ai, this volume) clearly suggest that tetrahydrobiopterin may be a limiting or regulatory element in NO formation in vivo. In particular, NO formation by the constitutive endothelial cell enzyme does show the same sensitivity to inhibition and reconstitution of cellular pteridine synthesis as the cytokine induced enzyme (6) . This suggests a mechanism for the findings of C. A. Nichol's group, that spontaneously hypertensive rats show diminished tetrahydrobiopterin biosynthetic activity. Further, endothelium dependent relaxations are known to be impaired in spontaneously hypertensive rats. Thus, by its action on NO synthase, the diminished tetrahydrobiopterin level might lead to diminished NO dependent relaxations. Investigation of the effect of pteridine treatment on the blood pressure in spontaneously hypertensive rats revealed a significant effect of sepiapterin, whereas pterin 6-carboxylic acid or saline were ineffective. At this stage it is not clear whether the increased tetrahydrobiopterin levels caused by the sepiapterin treatment increases NO dependent responses only, or whether the effect seen is mediated by action of tetrahydrobiopterin on dopamine, serotonin or kidney function. The results of the ongoing studies will bring more light to this question.
Considering the multiple biological actions of NO in intracellular signalling, neuronal transmission and cytotoxicity, it appears likely that some of the unknown roles for tetrahydrobiopterin might be mediated by NO synthase. In this context it is intriguing that the retina as well as lymphocyte clones are known to contain NO synthase, what might provide a goal for tetrahydrobiopterin in synthesis in these tissues.
